SIRT3 and heart disorder: Many cardiac diseases with abnormal metabolism and energy homeostasis are liable to result in impaired SIRT3 activity in a manner similar to the FXN KO model, leading to abnormal mitochondrial protein acetylation in the heart and impaired cardiac function.